Biotech Firm IN8bio Eyes US$40 Million IPO

Clinical-stage biopharmaceutical company IN8bio, Inc. (Nasdaq: INAB) began trading on the Nasdaq Global Market today under the symbol “INAB”. The firm’s initial public offering is looking to raise US$40.0 million and is expected to close on August 3, 2021.

The offering consists of 4,000,000 common shares selling at US$10.00 per share. The company intends to use the proceeds of its offering on advancing the development of its two lead product candidates in T-cell therapies for treating cancer.

The company granted a 30-day over-allotment option to purchase additional 600,000 common shares at the same IPO price. B. Riley Securities, Inc. is acting as the sole bookrunner for the said offering.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

The New York-based biotech company is focused on developing and commercializing gamma-delta T cells to treat cancer patients. The firm reported US$8.6 million net loss in 2020 and an approximately US$15 million cash balance as of March 31, 2021


Information for this briefing was found via Edgar and IN8bio. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Goliath Extends Golden Gate Lode 130 Metres With 13.45 g/t Gold Equivalent Over 4.85 Metres

Questcorp Begins 600 Metre Phase 2B Drill Program at La Union

Related News

Gaming Giant Discord Reportedly Eyeing Public Listing

Social communications platform Discord is now preparing to enter the public markets with guidance from...

Saturday, March 29, 2025, 07:47:00 AM

Biopharmaceutical Firm DICE Therapeutics Prices Upsized US$204 Million IPO

Biopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market...

Thursday, September 16, 2021, 11:08:00 AM

Russian Real Estate Platform Cian Prices US$291 Million NYSE IPO

Online real estate classified ad platform Cian PLC (NYSE: CIAN) started trading on the New...

Monday, November 8, 2021, 02:17:00 PM

Language Platform Duolingo Files For IPO On Nasdaq

Language learning platform Duolingo Inc. announced Monday that it has filed a registration statement relating...

Tuesday, June 29, 2021, 10:53:00 AM

SPAC Patria Latin American Opportunity Acquisition Prices US$200 Million IPO

Special purpose acquisition company Patria Latin American Opportunity Acquisition Corp. (Nasdaq: PLAOU) started trading publicly...

Thursday, March 10, 2022, 02:21:00 PM